Reactualisation of the in Vitro Activity of Tetracycline Antibiotics

References

• Col NF, O’Connor RW. Estimating worldwide current antibiotic usage: report of task force 1. Rev Infect Dis. 1987; 9 (Suppl 3): 232–43.
   Google Scholar
• Levy SB, McMurry L. Plasmid-determined tetracycline resistance involves new transport systems for tetracycline. Nature. 1978; 276: 90–2.
   Google Scholar
• Fayolle F, Privitera G, Sebald M. Tetracycline transport in Bacteroides fragilis. Antimicrob Agents Chemother. 1980; 18: 502–5.
   Google Scholar
• McMurry LM, Cullinane JC, Petrucci Jr RE, Levy SB. Active uptake of tetracycline by membrane vesicles from susceptible Escherichia coli. Antimicrob Agents Chemother. 1981; 20: 307–13.
   Google Scholar
• Chopra I, Howe TGB, Linton AH et al. The tetracyclines: prospects at the beginning of the 1980’s. J Antimicrob Chemother. 1981; 8: 5.
   Google Scholar
• Chopra I, Howe TGB. Bacterial resistance to the tetracyclines. Microbiol Rev. 1978; 42: 707–24.
   Google Scholar
• McMurry LM, Petrucci Jr RE, Levy SB. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc Nail Acad Sci USA. 1980; 77: 3974–7.
   Google Scholar
• Mendez B, Tachibana C, Levy SB. Heterogeneity of tetracycline resistance determinants. Plasmid. 1980; 3: 99–108.
   Google Scholar
• Chopra I, Lacey RW, Connolly J. Biochemical and genetic basis of tetracycline resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 1974; 6: 397–404.
   Google Scholar
• Asheshov EH. The genetics of tetracycline resistance in Staphylococcus aureus. J Gen Microbiol. 1975; 88: 132–40.
   Google Scholar
• Foster TJ. Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria. Microbiol Rev. 1983; 47: 361–409.
   Google Scholar
• Lyon BR, Skurray R. Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol Rev. 1987; 51: 88–134.
   Google Scholar
• Burdett V. Identification of tetracyclinc-resis-tant R-plasmids in Streptococcus agalactiae (group B). Antimicrob Agents Chemother. 1980; 18: 753–60.
   Google Scholar
• Burdetl V, Inamine J. Rujagopalan S. Heterogeneity of tetracycline resistance determinants in Streptococcus. J Bacteriol. 1982; 149: 995–1004.
   Google Scholar
• Burdett V. Streptococcal tetracycline resistance mediated at the level of protein synthesis. J. Bacteriol. 1986; 165: 564–9.
   Google Scholar
• Roberts MC, Hillier SL, Hale J, Holmes KK, Kenny GE. Tetracycline resistance and tetM in pathogenic urogenital bacteria. Antimicrob Agents Chemother 1986; 30: 810–2.
   Google Scholar
• Clewell DB, Gawron-Burke C. Conjugative transposons and the dissemination of antibiotic resistance in streptococci. Annu Rev Microbiol. 1986; 40: 635–59.
   Google Scholar
• Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966; 45: 493–6.
   Google Scholar
• Markovitz N, Pohlod DJ, Saravolatz LD, Quinn EL. In vitro susceptibility patterns of methicillin-resistant and -susceptible Staphylococcus aureus strains in a population of parenteral drug abusers from 1972 to 1981. Antimicrob Agents Chemother. 1983; 23: 4507.
   Google Scholar
• McCormack RC, Kaye E, Hook EW. Resistance of group A streptococci to tetracycline. N Engl J Med. 1962; 267: 323–6.
   Google Scholar
• Robertson MH. Tetracycline-resistant 6-hemolytic streptococci in Southwest Essex: decline and fall. Br Med J. 1973; 4: 84–5.
   Google Scholar
• Nakae M, Murai T, Kaneko Y, Mitsuhashi S. Drug resistante to Streptococcus pyogenes isolated in Japan (1974–1975). Antimicrob Agents Chemother. 1977; 12: 427–8.
   Google Scholar
• Bourbeau P, Campos JM. Current antibiotic susceptibility of group A [hemolytic streptococci. J. Infect Dis. 1982; 145: 916.
   Google Scholar
• Freundlich LF, Zanfordino E, Rosenthal SL. Susceptibility of streptococci to newer tetracyclines and cephalosporins and to other antimicrobial agents. Am J Med Technol. 1979; 45: 835–9.
   Google Scholar
• Persson K M-S, Forsgren A. Antimicrobial susceptibility of group B streptococci. Eur J Clin Microbiol. 1986; 5: 165–7.
   Google Scholar
• Horodniceanu Th, Delbos Fr. Lcs streptoco-ques du groupe I) dans les infections humaines: identifications et sensibilite aux antibiotiques. Ann Microbiol (Inst Pasteur). 1980; 13 IB: 131–44.
   Google Scholar
• Turner GC. Tetracycline-resistant pncumococci in a general hospital. Lancet. 1968; 2: 1292–5.
   Google Scholar
• Gopalakrislina KV, Lerner PI. Tetracycline-resistant pncumococci: increasing incidence and cross-resistance to newer tetracyclines. Am Rev Respir Dis. 1973: 108: 1002–10.
   Google Scholar
• Latorre C, Juncosa T, Sanfeliu I. Antibiotic resistance and serotypes of 100 Streptococcus pneumoniae strains isolated in a children’s hospital in Barcelona, Spain. Antimicrob Agents Chemother. 1985; 28: 357–9.
   Google Scholar
• Vanhoof R, Christiaens F, Dierickx R, Coigneau H, Butzler J-P. In vitro evaluation of the antibiotic susceptibility of Streptococcus pneumoniae-, pneumococci relatively resistant to penicillin in Brussels. Acta Clin Belg. 1980; 35: 343–8.
   Google Scholar
• Goldstein FW, Dang Van A, Bouanchaud DM, Acar JF. Evolution de la resistance aux antibiotiques des pneumocoques et repartition de leurs types capsulaires. Pathol Biol. 197826: 173–80.
   Google Scholar
• O’Brien TF and the Members of Task Force 2. Resistance of bacteria to antibacterial agents: report of task force 2. Rev Infect Dis. 1987; 9 (Suppl 3): 244–60.
   Google Scholar
• Van Leeuwen WJ, Voogd CE, Guinee PAM, Manten A. Incidence of resistance to ampicillin, chloramphenicol, kanamycin, tetracycline and trimethoprim of Salmonella strains isolated in the Netherlands during 1975–1980. Antonie van Leeuwenhoek. 1982; 48: 85–96.
   Google Scholar
• Chasseur-Libotte ML, Ghysels G. Evolution de la resistance aux antibiotiques des Salmonella en Bclgique de 1975 a 1981. Med Mai Infect. 1983; 13: 332–7.
   Google Scholar
• Fass RJ, Barnishan J. In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. Rev Infect Dis. 1980; 2: 841–53.
   Google Scholar
• Obana Y, Nishino T, Tanino T. In-vitro and in-vivo activities of antimicrobial agents against Acinetobacter calcoaceticus. J An-timicrob Chemother. 1985; 15: 441–8.
   Google Scholar
• Bergogne-Berezin E, Joly-Guillou ML. An underestimated nosocomial pathogen, Acinetobacter calcoaceticus. J Antimicrob Chemother. 1985; 16: 535–8.
   Google Scholar
• Crues 111 JV, Murray BE, Moellering Jr RC. In vitro activity of three tetracycline antibiotics against Acinetobacter calcoaceticus subsp. anitratus. Antimicrob Age/its Clwmotlier. 1979; 16: 690–2.
   Google Scholar
• Palenque E, Otero JR, Noriega AR. High prevalence of non-epidemic Shigella sonnei resistant to co-trimoxazolc. J Antimicrob Chemother. 1983; 11: 196–8.
   Google Scholar
• Ling J, Kam KM, Lam AW, French GL. Susceptibility of Hong Kong isolates of multiply resistant Shigella spp. to 25 antimicrobial agents, including ampicillin plus sulbactam and new 4-quinolones. Antimicrob Agents Chemother. 1988; 32: 20–3.
   Google Scholar
• Rowe B, Threlfall EJ. Drug resistance in gram-negative aerobic bacilli. Br Med Bull. 1984; 40: 68–76.
   Google Scholar
• Taylor DE, De Grandis SA, Karmali MA, Fleming PC. Transmissible plasmids from Campylobacter jejuni. Antimicrob Agents Chemother. 1981; 19: 831–5.
   Google Scholar
• Vanhoof R, Goossens H, Coignau 11, Stas G, Butzler JP. Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents. Antimicrob Agents Chemother. 1982; 21:990–2.
   Google Scholar
• Sagara H, Mochizuki A, Okamura N, Nakaya R. Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasm id profiles of Japanese clinical isolates. Antimicrob Agents Chemother. 1987; 31: 713–9.
   Google Scholar
• Tenover FC, Williams S, Gordon KP, Nolan C, Plorde JJ. Survey of plasmids and resistance factors in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother. 1985; 27: 37–41.
   Google Scholar
• Taylor DE, Garner RS, Allen BJ. Characterization of tetracycline resistance plasmids from Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother. 1983; 24: 930–5.
   Google Scholar
• Taylor DE. Plasmid-mediated tetracycline resistance in Campylobacter jejeuni: expression in Escherichia coli and identification of homology wilh streptococcal class M determinantJ.. Bacteriol. 1986; 165: 1037–9.
   Google Scholar
• Vanhoof R, Vanderlinden MP. Dierickx R. Lauwers S, Yourassowsky E, Butzler JP. Susceptibility of Campylobacter fetus subsp jejuni to twenty-nine antimicrobial agents. An timicrob Agents Chemother. 1978; 14: 553–6.
   Google Scholar
• DuPont liL, Galindo E, Evans DG, Cabada FJ, Sullivan P, Evans Jr DJ. Prevention of travellers’ diarrhea with trimethoprim-sulfamethoxazole and trimethoprim alone. Gastroenterology. 1983; 84: 75–80.
   Google Scholar
• Williams JD, Andrews J. Sensitivity ol Haemophilus influenzae to antibiotics. Br Med J. 1974; 1: 134–7.
   Google Scholar
• Philpott-Howard J, Williams JD. Increase in antibiotic resistance in Haemophilus influenzae in the United Kingdom since 1977: report of study group. Br Med J. 1982; 284: 1597–9.
   Google Scholar
• Piot P, Claeys G, Lauwers S, et al.Evolutie van de antimicrobiele gevoeligheid van Haemophilus influenzae in Vlaanderen. Belg Tijdschr voor Geneesk. 1983; 39: 747–52.
   Google Scholar
• Campos J, Garcia-Tornel S, Sanfeliu I Susceptibility studies of multiply resistant Haemophilus influenzae isolates from pediatric patients and contacts. Antimicrob Agents Chemother. 1984; 25: 706–9.
   Google Scholar
• Wood MJ, Farrell W, Kattan S. Williams JD. Activity of minocycline and tetracycline against pathogens related to blood levels. J. Antimicrob Chemother. 1975; 1: 323–31.
   Google Scholar
• Yourassowsky E, Schoutens E, Van Der Linden MP, Prudhomme MR. Susceptibility of Haemophilus to antibiotics: present status. Infection. 1975; 3: 15–8.
   Google Scholar
• Hager II, Verghese A, Alvarez S, Berk SL. Branhamella catarrhal respiratory infections. Rev Infect Dis. 1987; 9: 1140–49.
   Google Scholar
• Cannon JG, Sparling PF. The genetics ot the gonococcus. Annu Rev Microbiol. 1984; 38: 111–33.
   Google Scholar
• Sparling PF, Sarubbi FA, Blackmail E. Inheritance of low-level resistance lo penicillin, tetracycline and chloramphenicol in Neisseria gonorrhoeae. J Bacteriol. 1975; 124: 740–9.
   Google Scholar
• Mouton RP, van Klingeren B. Standaardisatie van Gevoeligheidsbepalingen. Verslag van de Werkgroep richtlijnen gevoeligheids bepalingen: Rijksinstitimt voor Volksgezondheid en Milieuhygiene, Nederland. 1985; Supplement I.
   Google Scholar
• Morse SA, Johnson SR, Biddle JW, Roberts MC. High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant. Antimicrob Agents Chemother; 1986; 30: 664–70.
   Google Scholar
• Franke AE, Clewell DB. Evidence for a chromosome-borne resistance transposon (Tn 916) in Streptococcus faecalis that is capable of “conjugal” transfer in the absence of a conjugate plasmid. J. Bacteriol. 1981; 145: 494502.
   Google Scholar
• Albritton WL, Maclcan IW, Slancy LA, Ronald AR, Dencer MG. Plasmid-mediatcd tetracycline resistance in Haemophilus ducreyi. Antimicrob Agents Chemother. 1984; 25: 18790.
   Google Scholar
• Stevens D, Higbee JW, Oberhofer TR, Everett ED. Antibiotic susceptibility of human isolates of Pasteurella multocida. Antimicrob Agents Chemother. 1979; 16: 322–4.
   Google Scholar
• de Rautin de la Roy Y, Paute MC, Grollier G, Grignon B. Isolement de Pasteurella multocida dans les infections broncho-pulmonaires. A propos de cinq nouveaux cas. Med Mai Infect. 1982; 12: 254.
   Google Scholar
• Sawyer WD, Dangerfield HG, Hogge AL et al. Antibiotic prophylaxis and therapy of airborne tularemia. Bacteriol Rev. 1966; 30: 542.
   Google Scholar
• Farrell ID, Hinchliffe PM, Robertson L. Sensitivity of Brucella spp to tetracycline and its analogues. J Clin Pathol. 1976; 29: 1097–1100.
   Google Scholar
• Shames JM, George RB, Holliday WB et al. Comparison of antibiotics in the treatment of mycoplasmal pneumonia. Arch Intern Med. 1970; 125: 680.
   Google Scholar
• Hjelm E, Jonsell G, Linglof T, Mardh P-A, Moller B, Scdin G. Meningitis in a newborn infant caused by Mycoplasma hominis. Acta Paediatr Scand. 1980; 69: 415–8.
   Google Scholar
• Koutsky LA, Stamm WE, Brunham RC, et al. Persistence of Mycoplasma hominis after therapy: importance of tetracycline resistance and of coexisting vaginal flora. .S‘ca’ Transm Dis. 1983; 11: 374–81.
   Google Scholar
• Roberts MC, Koutsky LA, Holmes KK, Leblanc DG, Kenny GE. Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob Agents Chemother. 1985; 28: 141–3.
   Google Scholar
• Roberts MC, Kenny GE. Dissemination of the tetM tetracycline resistance determinant to Ureaplasma urealyticum. Antimicrob Agents Chemother. 1986; 29: 350’2.
   Google Scholar
• Magelhaes M. Persistent nongonococcal urethritis associated with a minocycline-resis-tant strain of Ureaplasma urealyticum: a case report. Sex Transm Dis. 1983; 10: 151–2.
   Google Scholar
• Sanders LL, Harrison HR, Washington AE. Treatment of sexually transmitted chlamydial infections. JAMA. 1986; 255: 1750–6.
   Google Scholar
• Edelstein Ph, Meyer RD. Susceptibility of Legionella pneumophila to twenty antimicrobial agents. Antimicrob Agents Chemother. 1980; 18: 403–8.
   Google Scholar
• Nash P, Sideman L, Pidcoe V, Kleger B. Minocycline in Legionnaires’ disease. Lancet. 1978; i: 45.
   Google Scholar
• Cunha BA, Jonas M. Legionnaires’ disease treated with doxycycline. Lancet. 1981; i: 1107.
   Google Scholar
• Bach MC, Monaco AP, Finland M. Pulmonary nocardiosis: therapy with minocycline and with erythromycin plus am-picillin. JAMA. 1973; 224: 1378–81.
   Google Scholar
• Wren MV, Savage AM, Alford RH. Apparent cure of intracranial Nocardia asteroides infection by minocycline. Arch Intern Med. 1979; 139: 249–50.
   Google Scholar
• Sanders WJ, Wolinsky E. In vitro susceptibility of Mycobacterium marinum to eight antimicrobial agents. Antimicrob Agents Chemother. 1980; 18: 529–31.
   Google Scholar
• Wallace RJ, Swenson JM, Silcox VA, Bullen MG. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis 1985; 152: 500–14.
   Google Scholar
• Finegold (ed). Anaerobic Bacteria in Human Disease. Academic Press, New York, London, 1977.
   Google Scholar